Severe neurological events following liver transplantation.
暂无分享,去创建一个
C. Broelsch | A. Radtke | Yanli Gu | A. Paul | F. Saner | G. C. Sotiropoulos | J. Gensicke | I. Kavuk | M. Malágo
[1] H. Vinters,et al. Neuropathologic findings after liver transplantation , 2004, Acta Neuropathologica.
[2] P. Howdle,et al. Neurologic complications of liver transplantation in adults , 2003, Neurology.
[3] T. Egelhof,et al. Late onset of tacrolimus‐related posterior leukoencephalopathy after living donor liver transplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[4] W. Bechstein,et al. Neurotoxicity of calcineurin inhibitors: impact and clinical management , 2000, Transplant international : official journal of the European Society for Organ Transplantation.
[5] Charles M. Miller,et al. Central nervous system complications in liver transplant recipients – incidence, timing, and long‐term follow‐up , 2000, Clinical transplantation.
[6] J. Sageshima,et al. Clinical and radiological features of two cases of tacrolimus-related posterior leukoencephalopathy in living related liver transplantation. , 1998, Transplantation proceedings.
[7] A. Martínez,et al. The neuropathology of organ transplantation: comparison and contrast in 500 patients. , 1998, Pathology, research and practice.
[8] R. Wiesner,et al. Causes and outcome of seizures in liver transplant recipients , 1996, Neurology.
[9] L R Caplan,et al. A reversible posterior leukoencephalopathy syndrome. , 1996, The New England journal of medicine.
[10] J. Buckels. Liver transplantation: current status, complications and prevention. , 1995, The Journal of antimicrobial chemotherapy.
[11] R. Busuttil,et al. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. , 1995, Transplantation.
[12] W. Bechstein,et al. Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506. , 1994, Transplantation.
[13] E. Tolosa,et al. Predictive factors of in‐hospital CNS complications following liver transplantation , 1994, Neurology.
[14] R. Wiesner,et al. FK506‐induced neurotoxicity in liver transplantation , 1994, Annals of neurology.
[15] M. Schwartz,et al. Neurologic complications of orthotopic liver transplantation. , 1994, The Mount Sinai journal of medicine, New York.
[16] C. Lumbreras,et al. Neurologic complications in liver transplantation , 1993, Acta neurologica Scandinavica.
[17] D. V. van Thiel,et al. Neurological complications after liver retransplantation , 1992, Hepatology.
[18] W. Carey,et al. Neurological complications following liver transplantation , 1992, Annals of neurology.
[19] J. Roberts,et al. Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient. , 1991, Transplantation proceedings.
[20] C. Estol,et al. Seizures after liver transplantation , 1989, Neurology.
[21] W. Carey,et al. NEUROLOGIC COMPLICATIONS OF LIVER TRANSPLANTATION , 1988, Transplantation.
[22] G. Forbes,et al. Central Nervous System Toxicity after Liver Transplantation , 1987 .
[23] D. Adams,et al. NEUROLOGICAL COMPLICATIONS FOLLOWING LIVER TRANSPLANTATION , 1987, The Lancet.
[24] T. Starzl,et al. Refinements in the Surgical Technique of Liver Transplantation , 1985, Seminars in liver disease.
[25] T. Starzl,et al. HOMOTRANSPLANTATION OF THE LIVER IN HUMANS. , 1963, Surgery, gynecology & obstetrics.